» Articles » PMID: 19962808

Hypertension Awareness, Treatment, and Control in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study

Abstract

Background: A low rate of blood pressure control has been reported in patients with chronic kidney disease (CKD). These data were derived from population-based samples with a low rate of CKD awareness.

Study Design: Cross-sectional.

Setting & Participants: Data from the baseline visit of the Chronic Renal Insufficiency Cohort (CRIC) Study (n = 3,612) were analyzed. Participants with an estimated glomerular filtration rate of 20-70 mL/min/1.73 m(2) were identified from physician offices and review of laboratory databases.

Outcomes: Prevalence and awareness of hypertension, treatment patterns, control rates, and factors associated with hypertension control.

Measurements: Following a standardized protocol, blood pressure was measured 3 times by trained staff, and hypertension was defined as systolic blood pressure > or =140 mm Hg and/or diastolic blood pressure > or =90 mm Hg and/or self-reported antihypertensive medication use. Patients' awareness and treatment of hypertension were defined using self-report, and 2 levels of hypertension control were evaluated: systolic/diastolic blood pressure <140/90 and <130/80 mm Hg.

Results: The prevalence of hypertension was 85.7%, and 98.9% of CRIC participants were aware of this diagnosis and 98.3% were treated with medications, whereas 67.1% and 46.1% had hypertension controlled to <140/90 and <130/80 mm Hg, respectively. Of CRIC participants with hypertension, 15%, 25%, 26%, and 32% were using 1, 2, 3, and > or =4 antihypertensive medications, respectively. After multivariable adjustment, older patients, blacks, and those with higher urinary albumin excretion were less likely, whereas participants using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers were more likely to have controlled their hypertension to <140/90 and <130/80 mm Hg.

Limitations: Data were derived from a single study visit.

Conclusions: Despite almost universal hypertension awareness and treatment in this cohort of patients with CKD, rates of hypertension control were suboptimal.

Citing Articles

Risk factors of CVDs among residents of resource-limited rural settings. Preliminary findings based on a cross-sectional study, Ghana.

Konlan K, Afaya A, Anaman-Torgbor J, Adedia D, Todzro-Agudze M, Biney A BMC Cardiovasc Disord. 2025; 25(1):164.

PMID: 40055593 PMC: 11889812. DOI: 10.1186/s12872-025-04594-y.


Trends in Blood Pressure Control in US Adult CKD Patients from 1999 to 2018.

Sun A, Zhu L, Xia Y, Zheng Y, Hu B, Li F Int J Med Sci. 2025; 22(3):696-707.

PMID: 39898249 PMC: 11783084. DOI: 10.7150/ijms.103107.


Peroxiredoxin 5 Acts as a Negative Regulator of the Sodium-Chloride Cotransporter Involved in Alleviating Angiotensin II-Induced Hypertension.

Choi H, Jung I, Kim S Antioxidants (Basel). 2025; 14(1).

PMID: 39857434 PMC: 11761572. DOI: 10.3390/antiox14010100.


Prognostic value of nighttime blood pressure in patients with chronic kidney disease.

Li J, Wei Q, Li S, Song J, Wang C, Zhang J Hypertens Res. 2025; .

PMID: 39837965 DOI: 10.1038/s41440-024-02080-0.


Incidence, long-term predictors and progression of chronic kidney disease among African migrants and non-migrants: the transcontinental population-based prospective RODAM cohort study.

Mungamba M, Chilunga F, van der Linden E, Beune E, Godwill E, Hayfron-Benjamin C BMJ Glob Health. 2025; 10(1).

PMID: 39837584 PMC: 11749268. DOI: 10.1136/bmjgh-2024-016786.


References
1.
Anderson J, Konz E . Obesity and disease management: effects of weight loss on comorbid conditions. Obes Res. 2001; 9 Suppl 4:326S-334S. DOI: 10.1038/oby.2001.138. View

2.
Peralta C, Hicks L, Chertow G, Ayanian J, Vittinghoff E, Lin F . Control of hypertension in adults with chronic kidney disease in the United States. Hypertension. 2005; 45(6):1119-24. DOI: 10.1161/01.HYP.0000164577.81087.70. View

3.
Behrens T, Taeger D, Wellmann J, Keil U . Different methods to calculate effect estimates in cross-sectional studies. A comparison between prevalence odds ratio and prevalence ratio. Methods Inf Med. 2005; 43(5):505-9. View

4.
Feldman H, Appel L, Chertow G, Cifelli D, Cizman B, Daugirdas J . The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol. 2003; 14(7 Suppl 2):S148-53. DOI: 10.1097/01.asn.0000070149.78399.ce. View

5.
Parikh N, Hwang S, Larson M, Meigs J, Levy D, Fox C . Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Arch Intern Med. 2006; 166(17):1884-91. DOI: 10.1001/archinte.166.17.1884. View